Stocks · News reference

Quoin Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 results.

Aug 14, 2026, 3:11 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 20, 2026, 8:19 PMSEC EDGAR
8-K filing — Quoin Pharmaceuticals, Ltd. (QNRX)
Filed: 2026-08-20 AccNo: 0001104659-26-099239 Size: 207 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events
Read original at edgar
QNRX
BenzingaAug 14, 2026, 5:06 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.
Read original at benzinga
AKAN BEAT CAPR DARE ETON
BenzingaAug 14, 2026, 12:33 PMBenzinga Newsdesk
Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.90) per share which missed the analyst consensus estimate of $(1.61) by 18.01 percent. This is a 69.75 percent increase over losses of $(6.28) per
Read original at benzinga
QNRX